Publisher
Springer Berlin Heidelberg
Reference113 articles.
1. AGIS Investigators (2000) The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130:429–440
2. American Academy of Ophthalmology, Preferred Practice Pattern Guidelines (2015) Age Related Macular degeneration. San Francisco, CA, 2015. Age-Related Macular Degeneration PPP – Updated 2015. http://www.aao.org/preferred-practice-pattern/age-related-macular-degeneration-ppp-2015
3. Aroney C, Fraser-Bell S, Lamoureux EL, Gillies MC, Lim LL, Fenwick EK (2016) Vision-related quality of life outcomes in the BEVORDEX study: a clinical trial comparing Ozurdex sustained release dexamethasone intravitreal implant and bevacizumab treatment for diabetic macular edema. Invest Ophthalmol Vis Sci 57:5541–5546
4. Bahrami B, Hong T, Zhu M, Schlub TE, Chang A (2017) Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 255:1133–1140
5. Behrens-Baumann W, Begall T (1993) Antiseptics versus antibiotics in the treatment of the experimental conjunctivitis caused by staphylococcus aureus. Ger J Ophthalmol 2:409–411